A new study has shown how a protein called tau, a critical factor in the development of Alzheimer's disease, turns from normal to a disease state -- and demonstrates how the discovery could deliver a potential therapeutic target. Researchers hope to prevent the process from happening, thereby keeping tau in a healthy state and avoiding the toxic effects on brain cells that then result in impaired memory function.
